The forever war between America’s pharmaceutical industry and America’s public interest is approaching a climactic moment. At stake is whether Big Pharma and its allies will keep drug prices zooming upward, or whether the federal government can slow that rise by negotiating prices for some expensive drugs taken by Medicare beneficiaries.
Blue Shield of California today announced a range of 2022 coverage options for Medicare beneficiaries in California, with expanded benefits for food and transportation services.
A study of British patients with a long history of depression highlights how difficult it can be to stop medication, even for those who feel well enough to try.
The spread of COVID-19 vaccination requirements across the U.S. hasn't had the desired effect so far, with the number of Americans getting their first shots plunging in recent weeks. And some experts worry that the move to dispense boosters could just make matters worse.
More than a year after U.S. health care workers on the front lines against COVID-19 were saluted as heroes with nightly clapping from windows and balconies, some are being issued panic buttons in case of assault and ditching their scrubs before going out in public for fear of harassment.